• SENSEX 80,242.24
    -46.14 (--0.06%)
  • BANKNIFTY 55,391.25
    -41.55 (--0.07%)
  • Reliance Industr
    1,411.85 1,608.95(%)
  • Mazagon Dock
    3,149.70 3,047.00(%)
  • Bajaj Finance
    8,560.00 6,376.55(%)
  • Garden Reach Sh.
    1,855.00 890.05(%)
  • Cochin Shipyard
    1,575.50 1,169.00(%)
  • Tata Motors
    641.10 542.55(%)
  • Hind.Aeronautics
    4,466.00 3,045.95(%)
  • Paras Defence
    1,469.00 1,592.75(%)
  • Torrent Pharma.
    3,300.00 2,513.05(%)
  • Sonata Software
    446.50 762.00(%)
  • Data Pattern
    2,450.00 1,350.50(%)
  • IndusInd Bank
    843.10 1,550.00(%)
  • Samvardh. Mothe.
    131.75 107.30(%)
  • Bharat Electron
    312.50 221.00(%)
  • Trent
    5,130.00 4,058.45(%)
  • Varun Beverages
    507.45 419.40(%)
  • ICICI Bank
    1,415.10 1,051.50(%)
  • Vedanta
    423.20 527.00(%)
  • Hitachi Energy
    14,879.00 16,534.50(%)
  • Tech Mahindra
    1,510.60 1,807.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Lyka Labs Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 677.0
  • ISIN : INE933A01014
111.46 -1 (-0.54%)
  • As on 30 Apr 2025 (EOD)

  • Today’s Low

    109.99

  • Today’s High

    113.50

  • Open

    112.00

  • Perv Close

    112.06

  • 52W Low

    96.80

  • 52W High

    176.59

Key Indicators

  • P/E(TTM)

    74.63

  • Mar.Cap (₹Cr.)

    397.80

  • Div & Yield %

    0.00

  • Book Value(₹)

    36.64

  • Debt-Equity Ratio

    -0.54

  • AGM Date

    29-Apr-2025

  • EPS

    1.49

  • P/E Ratio

    74.63

Financials Ratios

  • Debt-Equity Ratio

    1.14

  • Mar.Cap (₹Cr.)

    397.80

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    35.69

  • BV (₹)

    36.60

  • Sales( ₹ in Cr.)

    106.40

  • NP (in Cr.)

    -2.31

  • NP Var(%)

    63.0

  • Div%

    0.0

  • CPS (₹)

    2.80

  • EPS (₹)

    -0.60

  • Traded Value (₹ in Lakhs)

    396.87

  • 52 Week High

    176.59

  • 52 Week Low

    96.80

  • Price BSE

    111.0

  • Price NSE

    111.00

  • Market Capital( in Cr.)

    396.87

  • P/C Ratio

    39.70

  • P/E Ratio

    -171.60

  • Price Vs.BV

    -0.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 106.40 80.59 164.35 62.26 40.74 41.18
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 106.40 80.59 164.35 62.26 40.74 41.18
Other Income 1.65 3.45 2.72 2.21 4.34 2.58
Stock Adjustments 0.79 1.21 0.40 -2.04 0.28 -0.60
Total Income 108.84 85.25 167.47 62.43 45.36 43.16
EXPENDITURE :            
Raw Materials 43.73 30.27 31.27 21.48 21.30 21.64
Power and Fuel Cost 3.92 3.57 3.88 2.91 2.52 2.22
Employee Cost 26.01 17.48 16.22 13.03 11.71 9.99
Other Manufacturing Expenses 2.53 2.81 2.25 2.27 1.40 1.05
Selling and Administration Expenses 15.23 11.18 12.04 5.63 5.43 4.13
Miscellaneous Expenses 1.26 8.06 6.26 1.91 31.38 1.05
Employee Benefit Expenses 26.01 17.48 16.22 13.03 11.71 9.99
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 92.68 73.37 71.93 47.22 73.74 40.08
Operating Profit 16.15 11.88 95.55 15.20 -28.37 3.07
Interest 4.80 11.57 19.92 25.55 19.01 5.73
Gross Profit 11.35 0.31 75.63 -10.35 -47.38 -2.66
Depreciation 12.29 13.52 15.39 8.05 7.77 4.44
Profit Before Tax -0.94 -13.21 60.24 -18.40 -55.15 -7.10
Current Tax 1.60 0.21 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.26 -0.13 20.34 -3.94 0.24 -8.83
Reported Net Profit -2.27 -13.29 39.90 -14.46 -55.39 1.73
Extraordinary Items 0.04 -7.06 -3.09 -1.43 -27.63 -0.53
Adjusted Net Profit -2.31 -6.23 42.99 -13.03 -27.76 2.26
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 -0.27
P & L Balance brought forward -101.38 -88.09 -127.99 -113.54 -58.15 -36.76
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -103.65 -101.38 -88.09 -127.99 -113.54 -35.29
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -0.69 -4.33 13.91 -5.04 -19.31 0.62
Earnings Per Share(Adj)-Unit Curr -0.69 -4.33 13.91 -5.04 -19.31 0.62
Book Value 27.28 19.22 15.49 1.54 6.55 34.77
Book Value(Adj)-Unit Curr 27.28 19.22 15.49 1.54 6.55 34.77

Shareholding Pattern

  • Promoter Group

    58.16%

  • Public Share Holding

    41.84%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 15,645,631 43.84 15,645,631 4
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,112,586 14.33 5,112,586 8
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 20,758,217 58.16 20,758,217 12
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 700 0.00 50 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 82,468 0.23 82,468 5
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 101,000 0.28 100,000 2
Mutual Funds / UTI 3,400 0.01 0 4
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 132,651 0.37 132,651 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 320,219 0.90 315,169 16
2] Non Institution
Bodies Corporate 1,943,172 5.44 1,942,310 173
Clearing Members 1,295 0.00 1,295 4
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 500 0.00 500 1
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 394,325 1.10 389,368 259
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 839,281 2.35 839,173 599
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,342,694 9.37 3,342,694 58
Individuals holding nominal share capital up to Rs. 1 lakh 7,785,117 21.81 7,585,756 27,333
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 14,611,564 40.94 14,405,776 28,444
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 35,690,000 100.00 35,479,162 28,472

Company Background

Lyka Labs LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Lyka Labs Ltd
  • BSE Code : 677.0
  • ISIN : INE933A01014

  • Incorporation Year

    1976

  • Registered Office

    4801/B & 4802/A
    GIDC Industrial Estate, Ankleshwar,
    Gujarat-393002

  • Telephone

    91-02646-221422/220549

  • FAX

    91-02646-250692

  • Chairman

    Babulal Jain

  • Managing Director

    KUNAL NARENDRA GANDHI

  • Company Secretary

    Shekhar R Singh

  • Auditor

    D Kothary & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Sharex Dynamic (India) Pvt Ltd
    C-101 247 Park ,
    L B S Marg ,Vikhroli West
    Mumbai - Mumbai - 400083

Lyka Labs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Lyka Labs 111.20 108.04 106.40 75.14 0.00
Abbott India 30,094.35 6,097.18 5,848.91 47.92 44.71
Astrazeneca Phar 8,795.90 1,330.33 1,295.53 226.76 33.26
P & G Health Ltd 5,121.00 1,166.89 1,151.26 35.93 39.76
Glaxosmi. Pharma 2,904.45 3,530.73 3,407.25 57.75 44.44
Cipla 1,541.00 17,645.00 16,574.34 26.42 20.10
Amrutanjan Healt 679.10 437.58 421.23 39.81 20.84
Guj. Themis Bio. 285.15 174.19 169.82 59.04 44.82
Fermenta Biotec. 272.25 315.24 307.09 25.81 4.10
Bliss GVS Pharma 122.65 638.96 605.46 28.07 11.19
Ambalal Sarabhai 37.10 11.70 3.81 15.85 1.92